Decreased Platelet-Free Dopamine and Unchanged Noradrenaline and Adrenaline in Essential Hypertension

 

PDF Download Buy Article Permissions and Reprints

Summary

The content of free-catecholamines in blood platelets is much higher than in plasma and platelet catecholamines must be taken up from plasma, since platelets lack the enzymes for catecholamine synthesis. There is some evidence that platelet catecholamine content under certain circumstances may be an integrated measure of plasma catecholamine concentrations over time. Platelet-free catecholamines were therefore assayed in 18 untreated patients with essential hypertension and in 16 normotensive control subjects. Mean platelet-free dopamine in the hypertensive group was 3.7 ± 0.4 pg/mg platelet weight, i.e. significantly less than the 6.5 ± 0.9 pg/mg found in the normotensive (p <0.005). Platelet contents of noradrenaline and adrenaline did not differ. Decreased platelet-free dopamine and unchanged platelet noradrenaline and adrenaline persisted after adjustment for increased body weight in the hypertensive group. Although the reasons for decreased platelet-free dopamine in the hypertensive group remain unknown, this finding may add to previous result showing facilitated release of granular contents from blood platelets in patients with essential hypertension. Our data do not support platelet levels of free-catecholamines to be a marker of increased sympathetic tone in essential hypertension.

• References

• 1 Da PradaM, Picotti GB. Content and subcellular localization of catecholamines and 5-hydroxytryptamine in human and animal blood platelets: monoamine distribution between platelets and plasma.. Br J Pharm 1979; 65: 653-662
  CrossrefPubMedGoogle Scholar
• 2 Picotti GB, Cesura AM, Galva MD, Mantegazza P, Kettler R, Da PradaM. Monoamine sulfoconjugation by human platelets:. In: Phenolsulfotransferase in Mental Health Research. Usdin E, Sandler M. (eds) MacMillan; New York : 1981. pp 44-54
  Google Scholar
• 3 McCulloch RK, Vandongen R, Tunney AM, Beilin LJ, Rogers PB. Distribution of free and sulfate-conjugated catecholamines in human platelets.. Am J Physiol 1987; 253E: 312-316
  PubMedGoogle Scholar
• 4 Gordon JL, Olverman HJ. 5-Hydroxytryptamine and dopamine transport by rat and human blood platelets.. Br J Pharmacol 1978 62: 219-226
  PubMedGoogle Scholar
• 5 Rosen SG, Sanfield JA, Morrow LA, Zweifler AJ. Relationship between plasma and platelet epinephrine concentrations in humans.. Am J Physiol 1987; 252E: 334-339
  PubMedGoogle Scholar
• 6 Kjeldsen SE, Westheim A, Lande K, Gjesdal K, Leren P, Enger E, Eide IK. Sodium depletion increases both platelet and plasma catecholamines in hypertensive men.. Hypertension 1988; 11: 477-482
  CrossrefPubMedGoogle Scholar
• 7 Ahtee L, Pentikainen PJ, Paasonen MK. 5-hydroxytryptamine in the blood platelets of cirrhotic and hypertensive patients.. Experientia 1974; 30: 1328-1329
  CrossrefPubMedGoogle Scholar
• 8 Bhargava KP, Raina N, Misra N, Shanker K, Vrat S. Uptake of serotonin in human platelets and its relevance to CNS involvement in hypertension.. Life Sci 1979; 25: 195-200
  CrossrefPubMedGoogle Scholar
• 9 Kamal LA, Le Quain-Bui KH, Meyer P. Decreased uptake of 3H- serotonin and endogenous content of serotonin in blood platelets in hypertensive patients.. Hypertension 1984; 6: 568-573
  CrossrefPubMedGoogle Scholar
• 10 Guicheney P, Baudouin-Legros M, Valtier D, Meyer P. Reduced serotonin content and uptake in platelets from patients with essential hypertension: Is a ouabain-like factor involved?. Thromb Research 1987; 45: 289-297
  CrossrefPubMedGoogle Scholar
• 11 Zweifler AJ, Julius S. Increased platelet catecholamine content in pheochromocytoma.. N Engl J Med 1982; 306: 890-894
  CrossrefPubMedGoogle Scholar
• 12 Leren P, Askevold EM, Foss OP, Frøilie A, Grymyr D, Helgeland A, Hjermann I, Holme I, Lund-Larsen PG, Norum KR. The Oslo Study. Cardiovascular disease in middle-aged and young Oslo men.. Acta Med Scand. 1975. Suppl 588.
  Google Scholar
• 13 Peuler JD, Johnson GA. Simultaneous single radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine.. Life Sci 1977; 21: 625-636
  CrossrefPubMedGoogle Scholar
• 14 Kjeldsen SE, Flaaten B, Eide I, Helgeland A, Leren P. Evidence of increased peripheral catecholamine release in patients with longstanding, untreated essential hypertension.. Scand J Clin Lab Invest 1982; 42: 217-223
  CrossrefPubMedGoogle Scholar
• 15 Kjeldsen SE, Flaaten B, Eide I, Helgeland A, Leren P, Fønstelien E. Decreased peripheral dopaminergic activity in essential hypertension?. Scand J Clin Lab Invest 1983; 43: 15-20
  CrossrefPubMedGoogle Scholar
• 16 Kjeldsen SE, Eide I, Aakesson I, Leren P. Increased arterial catecholamine concentrations in 50-year-old men with essential hypertension.. Scand J Clin Lab Invest 1983; 43: 343-349
  CrossrefPubMedGoogle Scholar
• 17 Stumpe KO, Kolloch R, Higuchi M, Kruck P, Vetter H. Hyperprolactinemia and antihypertensive effect of bromocriptine in essential hypertension.. Lancet 1977; 11: 211-214
  PubMedGoogle Scholar
• 18 Kolloch R, Kobayashi K, DeQuattro V. Dopaminergic control of sympathetic tone and blood pressure. Evidence of primary hypertension.. Hypertension 1980; 2: 390-394
  CrossrefPubMedGoogle Scholar
• 19 Os I, Kjeldsen SE, Westheim A, Aakesson I, Norman N, Enger E, Hjermann I, Eide I. Decreased central dopaminergic activity in essential hypertension.. J Hypertension 1987; 5: 191-197
  CrossrefPubMedGoogle Scholar
• 20 Os I, Kjeldsen SE, Westheim A, Lande K, Norman N, Hjermann I, Eide I. Endocrine and haemodynamic responses to graded dopamine infusion in essential hypertension.. Scand J Clin Lab Invest 1987; 47: 371-377
  CrossrefPubMedGoogle Scholar
• 21 Goldstein DS. Plasma catecholamines and essential hypertension. An analytical review.. Hypertension 1983; 5: 86-99
  CrossrefPubMedGoogle Scholar
• 22 Mattiasson I, Ohlin H. Sodium and noradrenaline effluxes from platelets in male relatives to hypertensive individuals.. Clin Exp Hypert 1987; A9 (11) 1859-1873
  PubMedGoogle Scholar
• 23 Lande K, Os I, Kjeldsen SE, Westheim A, Hjermann I, Eide I, Gjesdal K. Increased platelet size and release reaction in essential hypertension.. J Hypertension 1987; 5: 401-406
  PubMedGoogle Scholar
• 24 Kjeldsen SE, Lande K, Gjesdal K, Westheim A, Foss OP, Leren P, Eide IK. Increased platelet release reaction in 50-year-old men with essential hypertension. Correlation with atherogenic chlolesterol fractions.. Am Heart J 1987; 113: 151-155
  CrossrefPubMedGoogle Scholar
• 25 Kjeldsen SE, Gjesdal K, Eide I, Aakesson I, Amundsen R, Foss OP, Leren P. Increased p-thromboglobulin in essential hypertension: interactions between arterial plasma adrenaline, platelet function and blood lipids.. Acta Med Scand 1983; 213: 369-373
  PubMedGoogle Scholar
• 26 Palermo A, Bertalero P, Pizza N, Merati MG, Borchini M, Libretti A. Enhanced platelet serotonin release after adrenergic stress in arterial hypertension.. J Hypertension 1987; 5 (Suppl 5): S 141-143
  PubMedGoogle Scholar
• 27 Kuchel O, Buu NT, Hamet P, Nowaczynski W, Genest J. Free and conjugated dopamine in pheochromocytoma, primary aldosteronism and essential hypertension.. Hypertension 1979; 1: 267-273
  CrossrefPubMedGoogle Scholar